Evidence map›Paper›PMID 28657230›Full record

ReviewJournal of gynecologic oncology2017

Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: a Taiwanese Gynecologic Oncology Group (TGOG) study.

An Jen Chiang, Min Yu Chen, Chia Sui Weng, Hao Lin, Chien Hsing Lu, Peng Hui Wang, Yu Fang Huang, Ying Cheng Chiang, Mu Hsien Yu, Chih Long Chang

Open access · diamondAbstract readReview
In one paragraph

Review in Journal of gynecologic oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

An Jen ChiangDepartment of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.ORCID https://orcid.org/0000-0001-6892-8559
Min Yu ChenDepartment of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Chia Sui WengDepartment of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan.
Hao LinDepartment of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Chien Hsing LuDepartment of Obstetrics and Gynecology, National Yang-Ming University, Taipei, Taiwan.
Peng Hui WangDepartment of Obstetrics and Gynecology, National Yang-Ming University, Taipei, Taiwan.
Yu Fang HuangDepartment of Obstetrics and Gynecology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Ying Cheng ChiangDepartment of Obstetrics and Gynecology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Mu Hsien YuDepartment of Obstetrics and Gynecology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Chih Long ChangDepartment of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan.
Chang Gung University · TWMackay Memorial Hospital · TWNational Yang Ming Chiao Tung University · TWNational Cheng Kung University Hospital · TWNational Sun Yat-sen University · TWNational Taiwan University · TWTri-Service General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe malignant transformation (MT) of ovarian mature cystic teratoma (MCT) to squamous cell carcinoma (SCC) is very rare. This study analyzed cases from multiple medical centers in Taiwan to investigate the clinicopathologic characteristics, treatment, and prognostic factors of this disease and reviewed related literature.

methodsPathological reports of 16,001 patients with primary ovarian cancer who were treated at Taiwan medical centers from 1990 to 2011 were reviewed. In total, 52 patients with MT of MCT to SCC were identified.

resultsAmong all ovarian MCTs, the incidence of MT to SCC is 0.2%. The median age of patients was 52 years (range, 29-89 years), and the mean tumor size was 10.5 cm (range, 1-40 cm). We analyzed the patients in our study and those in the literature and determined that early identification and complete surgical resection of the tumor are essential for long-term survival. In addition, adjuvant chemotherapy or concurrent chemoradiotherapy can be used to treat this malignancy. Old age, large tumor size (≥15.0 cm), and solid components in MCTs are suitable indicators predicting the risk of MT of MCT to SCC.

conclusionSimilar to general epithelial ovarian cancers, the early detection of MT of MCT to SCC is critical to long-term survival. Therefore, older patients with a large tumor or those with a tumor containing a solid component in a clinically diagnosed MCT should be evaluated to exclude potential MT to SCC.

Indexed as

AdultAgedAged, 80 and overCarcinoma, Squamous CellCell Transformation, NeoplasticChemoradiotherapyChemotherapy, AdjuvantDiagnostic ImagingEarly Detection of CancerFemaleHumansMiddle AgedOvarian NeoplasmsPrognosisTaiwanTeratomaCell Transformation, NeoplasticSquamous Cell CarcinomaTeratoma

Identifiers

PMID28657230
PMCPMC5540728
OpenAlexW2625937527

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.